Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia A Howard

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|November 29, 2013
Azithromycin-induced proarrhythmia and cardiovascular deathPatricia A Howard
Hospital Pharmacy|June 25, 2014
Aspirin for primary cardiovascular prevention: when is it worth the risks?Patricia A Howard
Hospital Pharmacy|December 6, 2014
Diabetes and cardiovascular risk: are dipeptidyl peptidase-4 inhibitors beneficial?Patricia A Howard
The Annals of Pharmacotherapy|September 24, 2002
Aspirin resistancePatricia A Howard
The Annals of Pharmacotherapy|November 16, 2002
New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartionPatricia A Howard
Hospital Pharmacy|January 15, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: more choices bring more challengesPatricia A Howard
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|September 25, 2003
Low molecular weight heparins in special populationsPatricia A Howard
Hospital Pharmacy|September 26, 2015
Treating Heart Failure with Preserved Ejection Fraction: A Challenge for CliniciansPatricia A Howard
Hospital Pharmacy|June 25, 2014
Dabigatran for mechanical valvesPatricia A Howard
Journal of the American College of Cardiology|February 21, 2004
Nonsteroidal anti-Inflammatory drugs and cardiovascular riskPatricia A Howard, Patrice Delafontaine
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|November 29, 2013
Azithromycin-induced proarrhythmia and cardiovascular deathPatricia A Howard
Hospital Pharmacy|June 25, 2014
Aspirin for primary cardiovascular prevention: when is it worth the risks?Patricia A Howard
Hospital Pharmacy|December 6, 2014
Diabetes and cardiovascular risk: are dipeptidyl peptidase-4 inhibitors beneficial?Patricia A Howard
The Annals of Pharmacotherapy|September 24, 2002
Aspirin resistancePatricia A Howard
The Annals of Pharmacotherapy|November 16, 2002
New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartionPatricia A Howard
Hospital Pharmacy|January 15, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: more choices bring more challengesPatricia A Howard
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|September 25, 2003
Low molecular weight heparins in special populationsPatricia A Howard
Hospital Pharmacy|September 26, 2015
Treating Heart Failure with Preserved Ejection Fraction: A Challenge for CliniciansPatricia A Howard
Hospital Pharmacy|June 25, 2014
Dabigatran for mechanical valvesPatricia A Howard
Journal of the American College of Cardiology|February 21, 2004
Nonsteroidal anti-Inflammatory drugs and cardiovascular riskPatricia A Howard, Patrice Delafontaine
Pageof 5